Chapters:

Introduction0:00–0:39

Intrahepatic cholestasis of pregnancy, or ICP, is a rare pregnancy-specific liver disease that is characterized by pruritus and elevated serum bile acid levels.
Typically, it presents in the third trimester with itching on the palms of the hands and soles of the feet, without a rash.
It is a relatively uncommon disease but is associated with poor fetal outcomes, including preterm delivery, meconium-stained amniotic fluid, and stillbirth, due to an accumulation of bile acids in the fetus, as well as the amniotic fluid.

H&P and Labs0:39–4:15

Let’s talk about the first steps to assessing a patient… When assessing patients who present with a chief concern suggesting ICP, start with a focused history and physical exam as well as labs, including total bile acids and liver transaminases, such as ALT and AST.
The hallmark symptom of ICP is pruritus, most often on the palms of the hands and soles of the feet which is worse at night.
In general, symptoms start in the third trimester with the majority of cases diagnosed after 30 weeks gestation. Risk factors include a personal or family history of ICP or preexisting hepatobiliary diseases, such as hepatitis C, nonalcoholic cirrhosis, and nonalcoholic pancreatitis, as well as gallstones and cholecystitis.
ICP is also associated with advanced maternal age, multiple gestations, and in vitro fertilization. On physical exam, there should be no rash present.
If you visualize a rash, consider an alternative diagnosis, such as a dermatoses of pregnancy like atopic eruption of pregnancy, polymorphic eruption of pregnancy, or pemphigoid gestationis.
That being said, you may note excoriations, since the pruritus can be quite intense.When it comes to labs, the key finding in ICP is total bile acids greater than 10.
Your patient’s liver transaminases may also be elevated. If the total bile acids are greater than 10 along with pruritus of the palms and soles without a rash, you can make the diagnosis of ICP.
Also be sure to rule out other conditions that are associated with pruritus without a rash, such as chronic renal failure, liver disease, drugs such as opioids, and multiple sclerosis.
Here are a few clinical pearls about bile acids! When possible, check total bile acids in a fasting state, as there might be a small difference in levels between fasting and random blood work.
However, if this is not a possibility, random bile acids will do just fine, as the difference is usually clinically insignificant and not likely to change clinical management.
Additionally, if your patient’s total bile acids are initially normal and symptoms persist, repeat testing as indicated.
This is because itching can actually precede an elevation in bile acids by several weeks! Finally, total bile acid levels can be repeated after making the diagnosis, as an elevation >100 will change management!
This is because the higher the bile acids, the greater the risk for fetal complications. Before we move on, here are some high-yield facts!
Patients with bile acids greater than 40 are at an increased risk of developing preeclampsia. Preeclampsia typically develops a few weeks after the diagnosis of ICP, so it's important to discuss signs and symptoms to look out for with your patient.
Also, if your patient’s initial screening for HCV was negative but is diagnosed with ICP, you should screen them again after this diagnosis.Now that your patient has been diagnosed with ICP, let’s talk about management, starting with medical management.

Management4:15–7:17

The first line treatment is ursodeoxycholic acid, which is a naturally occurring bile acid that reduces both cholesterol secretion from the liver and reabsorption of cholesterol by the intestines.
It is used in patients with ICP to manage pruritus symptoms and generally takes 1 to 2 weeks to see improvement. If your patient’s symptoms are not relieved, the dose can be titrated up accordingly.
Keep in mind that, while ursodeoxycholic acid improves a pregnant person’s symptoms, it does not decrease fetal complications.
For patients whose symptoms are not well managed with ursodeoxycholic acid, consider the addition of antihistamines, which can help with intense pruritus.
Finally, administer corticosteroids for fetal lung maturity if delivery is indicated before 37 weeks of gestation. Here’s a clinical pearl!
Ursodeoxycholic acid can be discontinued postpartum, as symptoms and lab abnormalities generally resolve quickly after delivery.
However, don’t forget that ICP can recur in future pregnancies. Let’s switch gears and talk about fetal surveillance.
At the time ICP is diagnosed, it’s recommended to start antenatal fetal surveillance with non-stress tests and assessment of amniotic fluid volume.
Testing is generally performed one to two times a week. It's important to keep in mind that antenatal testing has not been shown to prevent stillbirth, but it remains the standard of care.
The reason that stillbirth is thought to be increased in patients with ICP is due to the effects of bile acids on the fetal heart, resulting in fetal arrhythmias, which can be sudden and not picked up during routine fetal surveillance.
Finally, let’s review recommendations for delivery timing. The risk of stillbirth increases around 36 to 37 weeks and is highest with total bile acids 100 or greater.
If your patient’s total bile acids are 10 to 99, then delivery is recommended between 36 weeks and 0 days to 39 weeks and 0 days.
However, if your patient’s bile acids are 100 or greater, then delivery is recommended at 36 weeks and 0 days. Remember to administer corticosteroids for fetal lung maturity if delivery is planned prior to 37 weeks.Another important part of management for your patients with ICP is continuous intrapartum fetal heart rate monitoring due to the risks of fetal complications.

Review7:17–8:04

Alright, as a quick recap… Intrahepatic cholestasis of pregnancy is a rare disease that can lead to severe fetal complications such as preterm delivery, meconium-stained amniotic fluid, and stillbirth.
The diagnosis is made clinically in patients with pruritus on the palms and soles along with elevated total bile acids greater than 10.
Patients with ICP are managed with ursodeoxycholic acid and possibly antihistamines to manage symptoms. They also require increased antepartum fetal surveillance, and delivery between 36 weeks and 0 days to 39 weeks and 0 days, with continuous intrapartum fetal heart rate
Cholestasis of pregnancy: Video, Causes, Symptoms | Osmosis